Drawing for Serial No. 79003730

USPTO serial 79003730

Serial No. 79003730

Reviewed by CopyMark Law Group

Reg. 3148834Status 404
Filing date
Status date
Registration date
Sep 26, 2006
Examiner
KING, LINDA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79003730?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Antibiotics; Antiallergic medicines, Antibacterial substances for medical purposes, Anticonvulsants, Antidepressants, Antidiabetic preparations, Antipyretic analgesics, Anti-cough drops, Anti-infective products for veterinary use, Bronchial dilators, Bronchodilators, Synthetic narcotics, Bacteriostats for medicinal, dental and veterinary use; Acne medications, Acne treatment preparations, Adjuvants for use with vaccines, Allergy medications, Anesthetics for non-surgical use, Anesthetics for surgical use, Anesthetics for surgical and non-surgical use, Anthelmintics, Antipyretic analgesics, Anti-itch cream, Anti-itch ointment, Bacterial and bacteriological preparations for medical or veterinary purposes, Blood substitute for human, Diuretics, Medicated bath preparations, Medicated lotions for skin, Medicated skin care preparations, Biochemical preparations for medical or veterinary purposes, Pharmaceutical products and preparations for hydrating the skin during pregnancy, Topical anesthetics, Articles for headache; Bacterial and bacteriological preparations for medical or veterinary purposes, Pharmaceutical antitussive-cold preparations, Pharmaceutical anti-allergic preparations and substances, Pharmaceutical for the treatment of erectile dysfunction, Pharmaceutical preparations for use in chemotherapy, Pharmaceutical preparation for the treatment of gout, Pharmaceutical preparations for the treatment of heart rhythm disorders, Pharmaceutical preparations for the treatment of infectious diseases Pharmaceutical preparations acting on the central nervous system, Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, Pharmaceutical preparations for animal skincare, Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, Pharmaceutical preparations for ocular or intraocular surgery, Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, Pharmaceutical preparations for treating allergic rhinitis and asthma, Pharmaceutical preparations for treating diabetes, Pharmaceutical preparations for treating skin disorders, Pharmaceutical preparations for use in dermatology, Pharmaceutical preparations for wounds, Pharmaceutical products and preparations against dry skin caused by pregnancy, Pharmaceutical products and preparations for chloasma, Pharmaceutical products and preparations for hydrating the skin during pregnancy, Pharmaceutical products and preparations for pregnancy blemishes, Pharmaceutical products and preparations for preventing skin blemishes during pregnancy, Pharmaceutical products and preparations to prevent stretch marks, Pharmaceutical products and preparations to prevent swelling in the legs, Pharmaceutical products for ophthalmological use, Pharmaceutical products for skin care for animals, Pharmaceutical products for the treatment of bone diseases, Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, Pharmaceutical products for treating respiratory diseases and asthma, Pharmaceutical skin lotions, Pharmaceutical solutions used in dialysis, Pharmaceuticals for the treatment of erectile dysfunction, Antibacterial pharmaceuticals, Anti-diabetic pharmaceuticals, Cardiovascular pharmaceuticals, Dermatological pharmaceutical products; Anesthetics for non-surgical use, Anesthetics for surgical and non-surgical use, Biological preparations for medical purposes, Biological and chemical preparations and reagents for medical or veterinary use, Ferments for medical or veterinary use, Topical anesthetics, Sterilizing preparations, Pharmaceutical preparations for use in chemotherapy, Veterinary vaccineSECTION 71 - CANCELLED—
016Stickers; paper labelsSECTION 71 - CANCELLED—
035Conducting marketing studies; import and export agencies; promoting the sales of goods and services of others through the distribution of printing material and promoting contests; dissemination of advertising matterSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 23, 2013DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Dec 23, 2013DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 30, 2013C71TCANCELLED SECTION 71—
May 2, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 7, 2008CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 1, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 1, 2007FIMPFINAL DISPOSITION PROCESSED—
Apr 26, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 26, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 4, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 14, 2006NPUBNOTICE OF PUBLICATION—
May 16, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 5, 2006ALIEASSIGNED TO LIE—
May 3, 2006CNEAEXAMINERS AMENDMENT MAILED—
May 3, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 3, 2006XAECEXAMINER'S AMENDMENT ENTERED—
May 3, 2006CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 26, 2006OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 5, 2006OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 5, 2006OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 4, 2005CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 4, 2005CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 4, 2005ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 12, 2005PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jun 21, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 17, 2005ALIEASSIGNED TO LIE—
Jun 16, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 14, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Jun 3, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 3, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 5, 2005CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 5, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 5, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 14, 2004RFNTREFUSAL PROCESSED BY IB—
Sep 14, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2004CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2004DOCKASSIGNED TO EXAMINER—
Aug 11, 2004NWAPNEW APPLICATION ENTERED—
Aug 9, 2004SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance